Technologies for Host Resilience (THoR)

The summary for the Technologies for Host Resilience (THoR) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the DARPA Biological Technologies Office, which is the U.S. government agency offering this grant.
Technologies for Host Resilience (THoR): This program strives to discover host tolerance mechanisms in order to identify a suite of interventions suitable for use in humans to mitigate the deleterious effects of infectious diseases. THoR is seeking novel methods and technologies to discover and understand these responses in hosts that are resilient when exposed to infectious diseases. Specifically, DARPA aims to discover the fundamental biological relationships that underlie host tolerance to infection in animal populations in order to provide the foundational knowledge required to develop interventions for potential transition into clinical use. This program is organized into three Technical Areas (TAs): 1) Identification and characterization of animal hosts with tolerant phenotypes; 2) Discovery of biological mechanisms that underlie tolerance; and 3) Identification of interventions that utilize tolerance mechanisms with the goal of reducing morbidity and mortality due to infection. This BAA will focus specifically on understanding tolerance mechanisms in prospective animal studies in conjunction with the analysis of retrospective pre-clinical and human clinical datasets.
Federal Grant Title: Technologies for Host Resilience (THoR)
Federal Agency Name: DARPA Biological Technologies Office
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: DARPA-BAA-15-21
Type of Funding: Other, Procurement Contract
CFDA Numbers: 12.910
CFDA Descriptions: Research and Technology Development
Current Application Deadline: May 19, 2015 4:00 pm eastern standard time
Original Application Deadline: May 19, 2015
Posted Date: Mar 31, 2015
Creation Date: Apr 1, 2015
Archive Date: Sep 30, 2015
Total Program Funding:
Maximum Federal Grant Award: none
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Link to Full Grant Announcement
DARPA-BAA-15-21 at FedBizOpps
Grant Announcement Contact
COL Matthew Hepburn, M.D. Program Manager Biological Technologies Office
BAA Coordinator

DARPA - Biological Technologies Office 571-218-4963
Similar Government Grants
Structures Uniquely Resolved to Guarantee Endurance (SURGE)
GOLDen hour extended EVACuation (GOLDEVAC)
Material Synthesis Technologies for Universal and Diverse Integration Opportunities (M-STU...
Scientific Feasibility (SciFy)
Expeditionary Carbon Utilization for energy Resilience and Stabilization (ExCURSion)
Wide Band Gap Semiconductors for RF Applications (WBGS-RF)
Robust Integrated Power Electronics (RIPE)
Microantenna Arrays:Technology and Applications (MIATA)
More Grants from the DARPA Biological Technologies Office
GOLDen hour extended EVACuation (GOLDEVAC)
BioLogical Undersea Energy (BLUE)
Objective Prediction of Team Effectiveness via Models of Performance Outcomes (OP TEMPO)
Assured Microbial Preservation in Harsh Or Remote Areas (AMPHORA)
Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD) is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024